BioSpace News Archive

Biotech Bay

American Lung Association Campaign Shines Spotlight on Endobronchial Valves for Advanced COPD/Emphysema

Pulmonx Corporation has partnered with American Lung Association to provide education to patients and providers on Endobronchial Valves, a clinically proven treatment to help people with severe COPD/emphysema breathe easier.1 COPD has no cure and is the third leading cause of death worldwide.

December 14, 2022
·
7 min read
BioCapital

Novavax Announces Proposed $125 Million Public Offering of Common Stock

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced a proposed underwritten public offering to sell up to $125 million of its common stock.

December 14, 2022
·
6 min read
Business

Centene Corporation Announces Leadership Changes and Appointments for Next Phase of Growth

Centene Corporation announced leadership changes and senior management appointments to position the Company for its next stage of growth.

December 14, 2022
·
16 min read
BioCapital

Novavax Announces Proposed Offering of $125 Million of Convertible Senior Notes

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced a proposed offering of $125 million aggregate principal amount of convertible senior notes due 2027.

December 14, 2022
·
7 min read
Business

Applied DNA Announces Fourth Quarter and Fiscal Year 2022 Financial Results

Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced consolidated financial results for the fourth quarter and fiscal year ended September 30, 2022.

December 14, 2022
·
16 min read
Genetown

CureVac Members of Management Sell Shares to Cover Tax Obligations from Long Term Incentive Program

CureVac N.V. announced that Chief Executive Officer Franz-Werner Haas, Chief Financial Officer Pierre Kemula and Interim Chief Development Officer Ulrike Gnad-Vogt sold an aggregate of 103,775 CureVac common shares.

December 14, 2022
·
4 min read
Biotech Bay

Biomea Fusion Announces FDA Clearance of Investigational New Drug (IND) Application for Covalent Menin Inhibitor BMF-219 in Type 2 Diabetes

Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA) today announced the U.S. Food and Drug Administration (FDA) has cleared Biomea’s IND application for BMF-219 in type 2 diabetes to support the expansion of the COVALENT-111 study to sites in the U.S.

December 14, 2022
·
8 min read
Policy

Ra Medical Systems Regains Compliance with NYSE American Continued Listing Standards

Ra Medical Systems, Inc. announces that it has received notification from the NYSE American LLC that the Company has regained compliance with the NYSE American’s continued listing standard.

December 14, 2022
·
1 min read
Business

Bolt Biotherapeutics Appoints Laura Berner to Board of Directors

Bolt Biotherapeutics, Inc. (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced the appointment of Laura Berner to its Board of Directors effective Dec. 14, 2022.

December 14, 2022
·
5 min read
BioMidwest

Majority of Stockholders Support Pasithea Directors at Special Meeting

Pasithea Therapeutics Corp., a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous system disorders, announced the final results of the Special Meeting of Stockholders held on December 9, 2022.

December 14, 2022
·
2 min read